| 查看: 65 | 回复: 0 | |||
| 当前主题已经存档。 | |||
[交流]
Clinical Pathways in Glaucoma
|
|||
|
Clinical Pathways in Glaucoma By Thom J. Zimmerman, Karanjit S. Kooner (Editors) Publisher: Thieme Medical Publishers Number Of Pages: 565 Publication Date: 2001-01-15 Sales Rank: 2480661 ISBN / ASIN: 0865779198 EAN: 9780865779198 Binding: Hardcover Manufacturer: Thieme Medical Publishers Studio: Thieme Medical Publishers With the goal of simplifying the diagnosis and treatment process, Drs. Zimmerman and Kooner introduce Clinical Pathways in Glaucoma. This new decision-making guide offers 22 chapters on topics ranging from childhood and neovascular glaucoma to drug-induced glaucoma and management of glaucoma in pregnancy. Each chapter is consistently laid out in the same organized format: Definition, Epidemiology and Importance, Diagnosis and Differential Diagnosis, Treatment and Management, and Future Considerations. Beneath each heading, a series of questions are posed, each followed by an answer and explanation, making it easy to quickly pinpoint the information you are looking for. Accompanied by step-by-step algorithms, cross-references, and dozens of drawings, charts and tables, Clinical Pathways in Glaucoma is a complete reference for specialists at all levels. This practical, clinically oriented text is designed for everyday use by ophthalmologists, glaucoma specialists, and residents. For easy- to-use, comprehensive information on today's challenging cases, Clinical Pathways in Glaucoma is ideal. PDF with bookmarks 4.3 Mb ; RAR 3.8 Mb pass: tFCLIPIG.rar http://rapidshare.com/files/38581407/CLIPIG.rar |
» 猜你喜欢
请问今年国家自然科学基金申报,是否还需要把代表性论文和获奖证明上传到附件中?
已经有4人回复
请问International Journal of Biological Macromolecules 这个期刊怎么样?
已经有16人回复
康复医学论文润色/翻译怎么收费?
已经有276人回复
请问今年国基申报,参与人有邮件确认环节吗?
已经有3人回复
三审将近2个月了还在peer review
已经有6人回复
有过类似经历的吗
已经有15人回复
295分调剂
已经有0人回复
【招生启事】澳门大学中华医药研究院国家重点实验室招收硕士博士研究生
已经有1人回复
中药神经药理、抑郁症相关机制以及神经发生研究方向博士申请自荐
已经有0人回复
求一个新加坡的神经科学癫痫方向的访问交流邀请函
已经有1人回复
Sage旗下期刊Awaiting Recommendation from AE后又变回Peer Review了
已经有2人回复









回复此楼